openPR Logo
Press release

Global Prenatal And New-born Genetic Testing Market Size Expected To Reach USD 13.4 Billion With CAGR 21.4% By 2032 : Report By Global Insight Services

12-26-2023 12:18 PM CET | Health & Medicine

Press release from: Global Insight Services

/ PR Agency: Global Insight Services
Global Prenatal And New-born Genetic Testing Market Size

The prenatal and newborn genetic testing market has undergone substantial growth, revolutionizing the landscape of reproductive and pediatric healthcare. Advancements in genetic screening technologies have significantly expanded the scope and accuracy of prenatal and newborn testing, enabling early detection of genetic disorders, chromosomal abnormalities, and hereditary conditions. This market's evolution is driven by the increasing emphasis on early disease detection, providing parents and healthcare providers with crucial insights into a child's health even before birth or in the early stages of life.

Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS10516/?utm_id=1023

These tests not only aid in risk assessment but also empower informed decision-making for expectant parents and facilitate early interventions, fostering improved clinical outcomes and personalized healthcare strategies for newborns. The continuous innovation in genetic testing methods, coupled with growing awareness and acceptance, positions the prenatal and newborn genetic testing market at the forefront of improving neonatal care and family planning.

Key Trends

An influential trend shaping the prenatal and newborn genetic testing market is the rapid integration of non-invasive prenatal testing (NIPT) and expanded genetic screening options. NIPT, leveraging cell-free fetal DNA from maternal blood, has gained immense traction due to its high accuracy in detecting chromosomal abnormalities like Down syndrome, without posing risks to the fetus. Moreover, the expanding spectrum of genetic screening panels now encompasses a wider range of genetic conditions, allowing for comprehensive assessment of potential risks early in pregnancy or at birth. This trend reflects a paradigm shift towards more extensive and accurate testing options, empowering parents with valuable genetic information and aiding healthcare providers in delivering tailored interventions and counseling, ultimately contributing to improved perinatal care and better health outcomes for newborns.

Read Full Research Report @ https://www.globalinsightservices.com/reports/prenatal-and-newborn-genetic-testing-market/?utm_id=1023

Key Drivers

A primary driver fueling the growth of the prenatal and newborn genetic testing market is the increasing awareness and adoption of precision medicine in reproductive and pediatric healthcare. The growing understanding of genetic factors influencing health and disease susceptibility in newborns, coupled with technological advancements, has propelled the demand for genetic testing during pregnancy and after birth. This trend is further augmented by the rising focus on personalized healthcare, wherein genetic testing provides valuable insights into potential risks of hereditary diseases and developmental disorders. Consequently, expectant parents and healthcare professionals are increasingly embracing genetic testing to assess risks, make informed decisions regarding pregnancies, and enable early interventions, underscoring the pivotal role of genetics in shaping individualized care strategies for both prenatal and newborn stages.

Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS10516/?utm_id=1023

Market Segmentation : Prenatal and New-born Genetic Testing Market

Prenatal and New-born Genetic Testing Market By Technology : Screening, Diagnostics

Prenatal and New-born Genetic Testing Market By Disease : Downs Syndrome, Cystic Fibrosis, Sickle Cell Anemia, Others

Prenatal and New-born Genetic Testing Market By End-use : Hospitals, Maternity & Specialty Clinics, Diagnostic Centers

Prenatal and New-born Genetic Testing Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Key Players :

Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Biorad
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health

Request for Customization @ https://www.globalinsightservices.com/request-customization/GIS10516/?utm_id=1023

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Prenatal And New-born Genetic Testing Market Size Expected To Reach USD 13.4 Billion With CAGR 21.4% By 2032 : Report By Global Insight Services here

News-ID: 3337901 • Views:

More Releases from Global Insight Services

Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4% Cagr. Key Players: Sustainalytics, Reprisk, Arabesque.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4 …
Market Overview ESG Risk Management Market is gaining significant momentum as businesses increasingly prioritize sustainability and ethical governance in their operations. Valued at $268.8 million in 2024, the market is projected to surge to $1,032.2 million by 2034, growing at a CAGR of 14.4%. The ESG Risk Management Market encompasses technologies and services designed to identify, monitor, and mitigate environmental, social, and governance risks, ensuring businesses operate responsibly while complying with
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4% Cagr. Key Players: Sonicwall, Watchguard, Palo Alto Networks.
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4 …
Market Overview Enterprise Firewall Market is witnessing substantial growth as organizations worldwide prioritize safeguarding their digital infrastructure from sophisticated cyber threats. Valued at $15 billion in 2024, the market is projected to reach $40.3 billion by 2034, expanding at a CAGR of 10.4%. The Enterprise Firewall Market encompasses solutions designed to secure enterprise networks by monitoring, filtering, and blocking unauthorized access while ensuring uninterrupted business operations. With the surge in cyberattacks,

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.